← Eichor
Condition: Early Stage Or Locally Advanced Her2 Positive Breast Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Early Stage Or Locally Advanced Her2 Positive Breast Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pyrotinib in Women With High-risk in Early Stage Breast Cancer
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05834764Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
Phase 2 · 1 location(s) · Peking University · NCT04481932SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT06927180A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced
Phase 3 · 2 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07196774
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.